Complete risk of bias assessment conducted using the RoB 2 tool of results included in the Cochrane review Pharmacotherapies for cannabis dependence ( CD008940 )
Emails to authors and responses for data sets 3 and 4. Assigned risk of bias in data sets 3 and 4. Articles initially assigned as unclear risk also determined to be low, high, or further unclear risk
Characteristics of both groups of patients (n = 102) who initially received telbivudine therapy and then received a rescue therapy (at baseline and prior to rescue therapy).
